Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Retinal Degeneration

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Retinal Degeneration in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, X1
Ye, H1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Retinal Degeneration

ArticleYear
Long-term treatment with 3,4-methylenedioxymethamphetamine caused retina damage in C57BL/6 mice.
    Arquivos brasileiros de oftalmologia, 2019, 06-03, Volume: 82, Issue:5

    Topics: Animals; Apoptosis; Blotting, Western; Electroretinography; Eye Injuries; Mice; Mice, Inbred C57BL;

2019